EGFR–TKI-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients With Non–Small cell Lung Cancer

This comparative study uses data from the US Food and Drug Administration Adverse Event Reporting System database to investigate the association between treatment with nivolumab in combination with epidermal growth factor receptor-tyrosine kinase inhibitors and interstitial pneumonitis in patients with non–small cell lung cancer.

http://ift.tt/2D2ZT37